News

Beste collega’s ,

Naar analogie van de Italiaanse prevalentiestudie (cfr poster) “A multicenter observational study of early diagnosis of Gaucher Disease in patients with splenomegaly and/or thrombocytopenia” zouden wij (Genzyme in collaboratie met BHS ) graag een gelijkaardige prevalentiestudie starten in België. 

Chers Collègues,

Par analogie avec l’étude italienne de  prévalence (voir poster) “A multicenter observational study of early diagnosis of Gaucher Disease in patients with splenomegaly and/or thrombocytopenia”, nous aimerions (Genzyme en collaboration avec le BHS) lancer une étude de prévalence de la Maladie de gaucher similaire en Belgique.

Informatie

Information

The last years the concept of 'risk assessment' is introduced in several laws and guidelines in the field of tissue banking. Risk analysis is the review of the risks associated with a particular event, action or process. It is applied to ay action where risk may be analyzed on a quantitative basis. Also in tissue and cell banks it become an important issue.

The BVWB-ABBT organizes May 22th their 5th spring symposium: Risk Analysis.

More information: Spring Meeting - May 22th 2014 - Risk Analysis

BHS Training Course #7 will take place on May 24, 2014.

Please this page for all relevant information.

Dear colleague, dear participant,

The Belgian Hematology Society (BHS) has organized a postgraduate course in 2012-2014.

There have been 12 seminars covering all major topics in hematology, the last seminar is programmed on May 24, 2014.

As announced previously, the BHS will organize a final exam on the whole 2-yrs program.

• CLICK HERE FOR REGISTRATION

As of 2013 EHA’s membership fee is only € 20 for young hematologists (up to 36 years of age).

We believe EHA membership contributes to the development of the careers of young professionals and by that nurture a brighter future in European hematology.

ITP Medical Seminar

Date: Saturday April 5th 2014
Location: Letchworth Hall Hotel, Letchworth Lane, Letchworth Garden City, Herts, SG6 3NP, UK

This Saturday event is intended for haematologists, paediatricians, haematology/haemostasis nurses and other health professionals who may see patients with Immune Thrombocytopenia. The programme features leading specialists from the USA and UK and includes discussion groups, and a question forum.

Exceptionally good value at just £30 for a full day to include lunch! On site B & B also available (details on booking form and website)

Approved for 6 CPD credits from the Royal College of Pathologists. 

For further information contact info@itpsupport.org.uk / Book on line at http://www.itpsupport.org.uk/seminar.htm

Dear colleague,

It is my great pleasure to invite you to the talk of Chiara Bonini, entitled 'Adoptive immunotherapy of hematological malignancies with genetically redirected T cells', on Tuesday 18/2/2014, 11.30 am, at the Ghent University Hospital, BlokA, 6th floor.  

Here you can find more information.

Kind regards,

Tessa Kerre

For those interested in GERIATRIC ONCOLOGY, you can find here more information on SIOG, the international society of geriatric oncology.

14th SIOG meeting, Portugal (23 to 25 October 2014)

Become a member

SIOG 10 priorities brochure

2012-2014 SIOG Governance

Dear Colleague,

The Red Cells Committee has already asked you twice to participate in surveys. The first time was in 2007, with a demographic study of haemoglobinopathies in Belgium (Hemoglobin. 2008;32(3):279-85.).  Then it was in 2010-2011 with a European survey: "Facilities for patients with rare and very rare anaemias." The results were sent to the participants and will be published within a "white book" on the www.enerca.org site.

Our committee would like to focus on sickle cell disease in Belgium. Indeed, the Belgian plan on rare diseases is on-going. We believe that BHS should be part of this process. This could be achieved by establishing a map of sickle cell centres where patients are followed and the tools available in these centres for this type of patients. Our network would also be strengthened to the benefit of all.

If you are interested in this approach we invite you to complete the questionnaire available at:

https://qtrial.qualtrics.com/SE/?SID=SV_0VyEuToSWJWRrRb


It will take you about 5 minutes.

Thanking you in advance for your participation,
The Red Cells Committee

15 - 16 November 2013

The main targets of this event are:

*  To provide an overview on prevention, diagnosis and clinical management of thalassaemia and other haemoglobinopathies.
*  To provide the current gene therapy approach for thalassaemia treatment.
*  To review current situation of other rare anaemias patient’s community.
*  Interactive session for patients: For the first time in Italy, patients with rare anaemias will have the opportunity to join, in a common meeting, the most experienced European health professionals in these particular disorders.

Program
Website 

'Masterclass in Haematology : ALL in adults, a state-of-the-science lecture, followed by a discussion on relapsed ALL and ALL in older patients.

by: Dr.Nicola Gögbuget, Frankfurt, DE, Coördinator of the German ALL Trials office and senoir ALL clinical researcher.

Preferred attendance:  junior specialists in Haematology training.

On: Friday November 29th, 2013., 15:00h -18:30h.

At:  Ghent University Hospital, room 'Stromboli', building K12, 13th floor.

Catering provided.

Accreditation requested.

Organisation and further information: Prof.dr.Lucien Noens (09/3322131 or email)

Attendance is free, but reservation required!

Dear Colleague,

The Belgian MDS Guidelines that have been developed by the MDS subcommittee offer further guidance on how to optimally diagnose and treat your patients. Indeed, over the last years, progress has been made in the diagnosis of MDS, as well as in the possible treatment options.
I am very happy to invite you to the MDS symposium: “Belgian MDS Guidelines: from clinical study to daily practice”,
in order to present these guidelines. During this symposium, with a large number of interesting speakers we will touch upon the key points of the Belgian Guidelines publication and provide a forum for discussion. The sessions will be animated by Pr. Michel Delforge and Dr. Stef Meers. Additionally we will have the honor to welcome Pr. Fenaux.

Kind regards,

Prof. dr. Lucien Noens

Announcement
Register

Final announcement Expert Meeting "Severe bleeding: from basics to practice", Brussels November 28th, 2013 

Dear Friends and Colleagues, 

It is with our great pleasure to announce and invite you to join us at The 1^st World Congress on Controversies in Multiple Myeloma (COMy). This educational and stimulating Congress will be held in Bangkok, Thailand on January 23-25, 2014.

In the last 15 to 20 years significant advancements in the understanding of the pathophysiology of multiple myeloma and related malignancies have led to the adoption of new and effective therapies. Thus, the time has come for a thorough biological and clinical update.

Dear colleagues,

We are pleased to announce that the 4th Spring Meeting of the BVWB-ABBT will be held on Monday April 29, 2013 at UCL St-Luc from 19h-21h.

Subject will be ‘Cell Therapy: from research to bedside'. Please visit our website www.bvwb-abbt.be to find out more about the program and the invited speakers.

We are looking forward to welcome you at the meeting.

The Board of the Belgian Association of Tissue and Cell Banks

More information 

Georganiseerd door Werkgroep Stamcellaboratoria Nederland (WSN), Nederlandse Vereniging voor Ziekenhuisapothekers (NVZA), Vlaamse Vereninging voor Ziekenhuisapothekers (VZA) en Katholieke Universiteit Leuven (KU Leuven)

Programma

Date: Friday June 7th, 2013

Venue: ICC Ghent

 Invitation / Website

Le Namur Thrombosis and Hemostasis Center a le plaisir de vous inviter à son 3^ième symposium annuel:

Le Jeudi 25 avril 2013 au Château de la Poste, Domaine de Ronchinne, Maillen